Mariner’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $312K | Sell |
48,668
-2,238
| -4% | -$14.3K | ﹤0.01% | 2699 |
|
|
2025
Q1 | $180K | Buy |
50,906
+367
| +0.7% | +$1.3K | ﹤0.01% | 3041 |
|
|
2024
Q4 | $191K | Sell |
50,539
-5,795
| -10% | -$21.9K | ﹤0.01% | 3018 |
|
|
2024
Q3 | $183K | Sell |
56,334
-1,205
| -2% | -$3.9K | ﹤0.01% | 2961 |
|
|
2024
Q2 | $109K | Buy |
57,539
+8,271
| +17% | +$15.7K | ﹤0.01% | 2940 |
|
|
2024
Q1 | $140K | Sell |
49,268
-163
| -0.3% | -$463 | ﹤0.01% | 2861 |
|
|
2023
Q4 | $728K | Buy |
49,431
+806
| +2% | +$11.9K | ﹤0.01% | 1665 |
|
|
2023
Q3 | $890K | Sell |
48,625
-17
| -0% | -$311 | ﹤0.01% | 1384 |
|
|
2023
Q2 | $1.05M | Buy |
48,642
+37
| +0.1% | +$798 | ﹤0.01% | 1279 |
|
|
2023
Q1 | $1.43M | Buy |
48,605
+10,614
| +28% | +$311K | ﹤0.01% | 1109 |
|
|
2022
Q4 | $1.4M | Buy |
+37,991
| New | +$1.4M | ﹤0.01% | 1082 |
|